Clinical decision support
Personalizing care, improving patient outcomes and reducing healthcare costs
For research use only. Not for use in diagnostic procedures.

We believe in more effective and affordable healthcare driven by a deeper understanding of a patient's disease

Actionable insights for complex diseases
Our clinical decision support platform interprets mechanostic test results, creating personalized precision medicine reports based on the patient’s underlying disease mechanisms.
Reports include actionable insights, including:
Patient's lifetime disease risk
Disease-associated mechanisms with supporting evidence
Associated symptoms
Effective treatment recommendations
Eligible clinical trials for likely effective treatments
Maximize patient outcomes
Tailor care to disease mechanisms, ensuring proactive intervention, accurate triage, and effective treatment.
Reduce time and costs
Stop inaccurate referrals, ineffective prescriptions, and the progression of unmanaged disease.
Prevent chronic disease
Determine lifetime risk of disease and protect with targeted preventative medicines to delay onset and stop disease progression.
The only tool that converts a patient's disease mechanisms into actionable insights to predict, treat, and prevent chronic diseases
Identify disease risks early
The CDS identifies lifetime risks of disease, enabling earlier detection and proactive intervention before symptoms arise.
Triage patients accurately
The CDS differentiates complex conditions with overlapping symptoms, enabling accurate diagnoses and differential triage.
Predict disease trajectory
The CDS analyzes genetic mechanisms to predict disease progression, guiding personalized monitoring and care pathways.
Select the right treatment
The CDS can match therapies to individual genetic profiles, guiding precision treatments for better patient outcomes.


Seamless integration
Our clinical decision support system seamlessly deploys inside multiple HIPAA/GDPR protected clinical environments, integrating into existing workflows.
Trust & transparency
Our reports are based on a simple count of genotypic signatures identified by our mechnostic tests. There's no complex polygenic risk score models or black box AI – our findings are reproducible and explainable.
We remove the bias of machine learning software and avoid the main issues of concern to regulators around software interpretation and AI.
Sample collection
Minimally invasive buccal swab or blood sample taken by the patient at home or in their primary care setting.
Genotyping & analysis
The sample is tested against a well-known genotyping array using industry standard equipment to generate a comprehensive genetic profile.
Mechanistic interpretation
Our clinical decision support platform interprets the results, identifying disease-associated mechanisms and generating a clear report for the clinician.
Disease risk & cause
Report predicts disease risk before symptoms appear and determine the causative mechanisms underpinning disease to personalize care.
Predict & prevent chronic diseases
Mechanostic precision medicine tests and actively protective therapies offer significant benefits - identifying people at risk, selecting effective interventions and enabling disease prevention - improving patient outcomes and reducing cost of care.
Let's talk
Patients are counting on us
We're helping more and more partners to achieve better health for patients, faster.
Contact us to find out more.